The Role of Non-Coding RNAs in Mitochondrial Dysfunction of Alzheimer’s Disease
- 28 October 2024
- journal article
- review article
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 74 (4) , 1-20
Abstract
Although brain amyloid-β (Aβ) peptide buildup is the main cause of Alzheimer’s disease (AD), mitochondrial abnormalities can also contribute to the illness’s development, as either a primary or secondary factor, as programmed cell death and efficient energy generation depend on the proper operation of mitochondria. As a result, non-coding RNAs (ncRNAs) may play a crucial role in ensuring that nuclear genes related to mitochondria and mitochondrial genes function normally. Interestingly, a significant number of recent studies have focused on the impact of ncRNAs on the expression of nucleus and mitochondrial genes. Additionally, researchers have proposed some intriguing therapeutic approaches to treat and reduce the severity of AD by adjusting the levels of these ncRNAs. The goal of this work was to consolidate the existing knowledge in this field of study by systematically investigating ncRNAs, with a particular emphasis on microRNAs (miRNAs), long non-coding RNAs (lncRNAs), circular RNAs (circRNAs), and small nucleolar RNAs (snoRNAs). Therefore, the impact and processes by which ncRNAs govern mitochondrial activity in the onset and progression of AD are thoroughly reviewed in this article. Collectively, the effects of ncRNAs on physiological and molecular mechanisms associated with mitochondrial abnormalities that exacerbate AD are thoroughly reviewed in the current research, while also emphasizing the relationship between disturbed mitophagy in AD and ncRNAs.Keywords
Funding Information
- Tabriz University of Medical Sciences (71807)
This publication has 131 references indexed in Scilit:
- 2023 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2023
- Nano‐Brake Halts Mitochondrial Dysfunction Cascade to Alleviate Neuropathology and Rescue Alzheimer's Cognitive DeficitsAdvanced Science, 2023
- MiRNA-137-mediated modulation of mitochondrial dynamics regulates human neural stem cell fateStem Cells, 2020
- Quantitation of in vivo brain glutathione conformers in cingulate cortex among age‐matched control, MCI, and AD patients using MEGA‐PRESSHuman Brain Mapping, 2019
- Upregulation of the lncRNA MEG3 improves cognitive impairment, alleviates neuronal damage, and inhibits activation of astrocytes in hippocampus tissues in Alzheimer's disease through inactivating the PI3K/Akt signaling pathwayJournal of Cellular Biochemistry, 2019
- Administration of resveratrol improved Parkinson’s disease‐like phenotype by suppressing apoptosis of neurons via modulating the MALAT1/miR‐129/SNCA signaling pathwayJournal of Cellular Biochemistry, 2018
- Noncoding RNAs in Alzheimer's diseaseWIREs RNA, 2018
- MicroRNA-338 regulates the axonal expression of multiple nuclear-encoded mitochondrial mRNAs encoding subunits of the oxidative phosphorylation machineryCellular and Molecular Life Sciences, 2012
- Control of mitochondrial activity by miRNAsJournal of Cellular Biochemistry, 2011
- Marked Changes in Mitochondrial DNA Deletion Levels in Alzheimer BrainsGenomics, 1994